Journal of hepatologyJClub144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.
Journal of hepatology · · Randomized Controlled Trial · Open access
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial.
Wedemeyer, Aleman + more
Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's. The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →